LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 89 filers reported holding LEGEND BIOTECH CORP in Q2 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,153 | -13.9% | 4,409 | -11.5% | 0.18% | -11.8% |
| Q2 2023 | $343,907 | +20.1% | 4,982 | -16.1% | 0.20% | +29.1% |
| Q1 2023 | $286,330 | -1.6% | 5,938 | +1.8% | 0.16% | +3.9% |
| Q4 2022 | $291,133 | +33.5% | 5,832 | +9.0% | 0.15% | +74.7% |
| Q3 2022 | $218,000 | -24.8% | 5,351 | +1.5% | 0.09% | -18.7% |
| Q2 2022 | $290,000 | +150.0% | 5,274 | +65.1% | 0.11% | +105.8% |
| Q1 2022 | $116,000 | -26.6% | 3,195 | -5.6% | 0.05% | -13.3% |
| Q4 2021 | $158,000 | -40.6% | 3,384 | -35.7% | 0.06% | -48.7% |
| Q3 2021 | $266,000 | +17.2% | 5,265 | -4.8% | 0.12% | +25.8% |
| Q2 2021 | $227,000 | -22.0% | 5,531 | -44.8% | 0.09% | -24.4% |
| Q1 2021 | $291,000 | +5.1% | 10,016 | +1.9% | 0.12% | +7.0% |
| Q4 2020 | $277,000 | – | 9,834 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |